Juvenile myelomonocytic leukemia overview

Juvenile myelomonocytic leukemia Microchapters
Home
Patient Info
Overview
Historical Perspective
Classification
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes of Juvenile myelomonocytic leukemia
Differentiating Juvenile myelomonocytic leukemia from other Diseases
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms
Physical Examination
Lab Tests
Electrocardiogram
Chest X Ray
MRI
CT
Echocardiography or Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgical Therapy
Radiation Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Juvenile myelomonocytic leukemia overview On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Juvenile myelomonocytic leukemia overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Juvenile myelomonocytic leukemia overview
CDC on Juvenile myelomonocytic leukemia overview
Juvenile myelomonocytic leukemia overview in the news
Blogs on Juvenile myelomonocytic leukemia overview
to Hospitals Treating Juvenile myelomonocytic leukemia
Risk calculators and risk factors for Juvenile myelomonocytic leukemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Juvenile myelomonocytic leukemia (JMML) is a serious chronic leukemia (cancer of the blood) that affects children mostly aged 4 and under. The average age of patients at diagnosis is 2 years old. The World Health Organization has included JMML in the category of Myelodysplastic and Myeloproliferative disorders. The name JMML now encompasses all diagnoses formerly referred to as Juvenile Chronic Myeloid Leukemia (JCML), Chronic Myelomonocytic Leukemia of Infancy, and Infantile Monosomy 7 Syndrome.

References

Template:WikiDoc Sources